BHARAT BIOTECH
COVID-19 Vaccine Update: India Approves SII's 'Covishield' and Bharat Biotech's 'Covaxin' Vaccines for Emergency Use
COVID-19 Vaccine Update: Bharat Biotech Recruits 23,000 Volunteers for Phase-3 Trials of Coronavirus Vaccine 'Covaxin'
Will India Get COVID-19 Vaccine Today? Drugs Controller General of India to Address Press Conference at 11 AM
Bharat Biotech Recruits 23,000 Volunteers for Phase 3 Clinical Trials of COVID-19 Vaccine 'Covaxin' Across Multiple Sites in India
Bharat Biotech's Covaxin Gets CDSCO Panel Nod, India's 2nd Vaccine Candidate to Receive Emergency Use Approval: Reports
COVID-19 Vaccination in India: No Approval For Covaxin, Expert Panel Seeks More Data From Bharat Biotech
COVID-19 Vaccine in India: CDSCO Expert Panel to Reconvene on January 1 to Consider Emergency Use Authorisation for Vaccines
COVID-19 Vaccine Latest Update: Serum, Bharat Biotech's Candidates Not Granted Emergency Use Authorisation, Expert Panel Seeks More Data
COVID-19 Vaccine Covaxin Generate Antibodies That May Persist for 6-12 Months, Says Bharat Biotech
COVID-19 Vaccine Latest Update: Bharat Biotech Again Applies for Emergency Use Authorization for Covaxin
COVID-19 Vaccine Update: Covaxin to be Co-Developed by Bharat Biotech, Ocugen for US Market
COVID-19 Vaccine Update: Inactivated Vaccines are Safest with Lesser Adverse Reactions, Says Bharat Biotech
Covaxin Phase 1 Test Results: Bharat Biotech COVID-19 Vaccine Candidate Triggers Immune Response, Shows No Serious Adverse Effect
India's COVID-19 Vaccine Status Tracker: A Look at SII, Bharat Biotech, Other Leading Candidates and Expected Dates of Launch
Google Trends